Orthocell Ltd (ASX:OCC, OTC:ORHHF) has reported that its Remplir™ nerve repair device has been used in 23 surgical procedures on Ukrainian soldiers injured in combat, marking an important real-world application of the technology in frontline trauma care.
The update follows a humanitarian delivery of Remplir to Ukraine in April 2025, with the company now receiving confirmation that the device has been successfully deployed by local surgeons in both primary and secondary nerve repair procedures.
Resolution Minerals Ltd (ASX:RML, OTCQB:RLMLF, FRA:NC3) is preparing to launch a major follow-up drilling campaign at its Horse Heaven gold-antimony-tungsten-silver project in Idaho, with the new program designed to build on the success of its 2025 work at Golden Gate and move the target closer to a maiden resource.
The company plans to begin a fully permitted Phase 2 diamond drilling program in early May 2026, comprising up to 45 holes for 13,700 metres at the Golden Gate fault zone. The campaign is a substantial step-up from the Phase 1 program completed in 2025, which totalled 3,780 metres across 14 holes.
Titan Minerals Ltd (ASX:TTM, OTC:TTTNF) has delivered a substantial upgrade to the mineral resource at its 100%-owned Dynasty Gold Project in southern Ecuador, lifting contained gold by 25% to 3.9 million ounces (Moz) and silver by 19% to 26.1Moz
The updated mineral resource estimate (MRE) now stands at 65.6 million tonnes at 1.85 g/t gold and 12.38 g/t silver, reflecting the impact of an extensive drilling campaign completed over the past year.
The S&P/ASX Small Ordinaries index (ASX: XSO) edged higher on the latest session, closing at 3,389.40, up 15.90 points or 0.47% for the day, although the index remains down 3.93% over the past five days, reflecting ongoing volatility across the small-cap space.
Against this mixed backdrop, several ASX-listed companies have reported resource upgrades, exploration progress and technology advancements, highlighting continued activity at the project level despite broader market weakness. You can read about the following and more throughout the day.
New Frontier Minerals Ltd (LSE:NFM, ASX:NFM, FRA:7OR0, OTCQB:NFMXF) shares rose 5% to 0.5p after the company said its Mining Lease Application for the Big One copper deposit in Queensland had cleared initial regulatory review and received technical assessment approval from the Queensland Natural Resources and Mines Department.
The milestone moves the project closer to potential near-term production.
Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF) has lined up access to about US$16.4 million in fresh funding as it pushes the Ewoyaa lithium project in Ghana toward production, bringing Ghanaian pension-fund investors onto its register while also drawing down the final tranche of its Long State Investments Ltd facility.
The funding package includes a US$11 million strategic investment facilitated by IC Asset Managers (Ghana), made up of an unconditional US$5 million share subscription and up to US$6 million from milestone-linked warrants.
The next phase of the weight-loss drug boom is taking shape — and it’s no longer just about who has the most effective injectable.
San Francisco-based biotech Structure Therapeutics (NASDAQ:GPCR) has reported Phase 2 topline results for its oral GLP-1 candidate aleniglipron, posting weight-loss outcomes the company says stack up favourably against leading next-generation drugs — including Eli Lilly and Co (NYSE:LLY)’s oral candidate orforglipron, which is widely expected to reach the market in the near term.
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) will host an online webinar on March 19, 2026, as the company updates investors on progress across its anti-infective portfolio.
The webinar will be held via Zoom at 10:30am AEDT and will be recorded for those unable to attend live.
The Reserve Bank of Australia has raised the cash rate by 25 basis points to 4.1% in a split decision, as the central bank moves to get ahead of an inflation threat it fears could be significantly worsened by the ongoing Iran conflict.
Five of the nine monetary policy committee members backed the move, with four voting to hold — a division that highlights the uncertainty of the board over how aggressively to respond to an oil-driven price shock.
Oil markets are scrambling for alternatives as the closure of the Strait of Hormuz continues to choke one of the world’s most critical energy corridors, with Saudi Arabia’s East-West Petroline rapidly stepping into focus as a partial workaround.
The escalation around Hormuz — now well known as the source of a fifth of global oil supply — has already triggered a sharp spike in crude prices amid the US and Israel’s ongoing conflict with Iran, with Brent peaking near US$106 a barrel and WTI above US$102. Even with the pullback, prices remain elevated (around US$102 for Brent and $95 for WTI on Tuesday) amid continued uncertainty over Hormuz supply flows, forcing producers, traders and refiners to rethink logistics in real time.
Prescient Therapeutics Ltd (ASX:PTX) is advancing enrolment in its Phase 2 clinical trial for lead asset PTX-100, with new research highlighting steady progress across trial execution, regulatory milestones and funding — while pointing to valuation upside from current levels.
A new report from Pitt Street Research outlines growing momentum behind PTX-100, a first-in-class oncology drug targeting relapsed or refractory cutaneous T-cell lymphoma (CTCL), a rare and difficult-to-treat cancer where treatment options remain limited.
Tetratherix Limited (ASX:TTX) is expanding beyond its core regenerative medicine portfolio, launching a new precision medicine franchise backed by a long-term US partnership that delivers immediate revenue.
The move builds on the company’s Tetramatrix™ platform, which already underpins its bone regeneration, tissue spacing and tissue healing programs, and now opens a pathway into drug delivery.
Magnetite Mines Ltd (ASX:MGT, OTCQB:RRSXF, FRA:RRSXF) has reported high-grade silver and copper mineralisation from a re-assay of archived diamond drill core at its Mutooroo Ridge project in South Australia, with the standout result returning 8 metres at 38.5 grams per tonne (g/t) silver.
Ark Mines Ltd (ASX:AHK) has secured a mining licence from the Queensland Government for its Sandy Mitchell rare earth elements and heavy minerals project in North Queensland, marking a key regulatory milestone as the company moves the asset closer to development.
The licence, granted over EPM 28013, covers about 406 hectares and includes the area hosting the project’s measured mineral resource estimate.
Evion Group NL (ASX:EVG, FRA:BAPA) executives have held a series of meetings in India with joint venture partners and strategic advisers as the company progresses upgrades at its expandable graphite facility to meet rising demand from Europe and the United States.The global expandable graphite market is projected to reach US$312.4 million by 2028 from an estimated US$205.9 million in 2022, at a CAGR of 7.2% during 2023 and 2028.
The discussions centred on development and expansion at the Panthera Graphite Technologies (PGT) plant near Pune, which is operated through a 50:50 joint venture with Metachem Manufacturing Co.
AuKing Mining Ltd (ASX:AKN) has transferred four uranium exploration tenements in Tanzania to Moab Minerals Ltd (ASX:MOM), allowing the company to streamline its portfolio and focus on core assets while retaining exposure to the Manyoni uranium project.
The licences sit adjacent to Moab’s Manyoni project in central Tanzania and have been transferred to Moab’s Tanzanian subsidiary Katika Resources Ltd under an asset sale and purchase agreement first announced in October 2024.